Virucidal efficacy of hypochlorous acid water for aqueous phase and atomization against SARS-CoV-2
- PMID: 38557574
- DOI: 10.2166/wh.2024.348
Virucidal efficacy of hypochlorous acid water for aqueous phase and atomization against SARS-CoV-2
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged at the end of 2019. SARS-CoV-2 can be transmitted through droplets, aerosols, and fomites. Disinfectants such as alcohol, quaternary ammonium salts, and chlorine-releasing agents, including hypochlorous acid, are used to prevent the spread of SARS-CoV-2 infection. In the present study, we investigated the efficacy of ionless hypochlorous acid water (HOCl) in suspension and by spraying to inactivate SARS-CoV-2. The virucidal efficacy of HOCl solution in tests against SARS-CoV-2 was evaluated as 50% tissue culture infectious dose. Although the presence of organic compounds influenced the virucidal efficacy, HOCl treatment for 20 s was significantly effective to inactivate Wuhan and Delta strains in the suspension test. HOCl atomization for several hours significantly reduced the SARS-CoV-2 attached to plastic plates. These results indicate that HOCl solution with elimination containing NaCl and other ions may have high virucidal efficacy against SARS-CoV-2. This study provides important information about the virucidal efficacy and use of HOCl solution.
Keywords: atomization; coronavirus disease 2019 (COVID-19); hypochlorous acid water (HOCl); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); suspension test.
© 2024 The Authors This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC BY 4.0), which permits copying, adaptation and redistribution, provided the original work is properly cited (http://creativecommons.org/licenses/by/4.0/).
References
-
- Alzahrani M. M., Bamashmous S., Alkharobi H., Alghamdi A., Alharbi R. H., Hassan A. M., Darwish M., Bukhari A., Mahmoud A. B., Alfaleh M. A., Mirza A. A., Abuzenadah A. M., Abujamel T. S. & Hashem A. M. 2022 Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial. Journal of Medical Virology 95, e28412.
-
- Aratani Y. 2018 Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Archives of Biochemistry and Biophysics 640, 47–52. - PubMed
-
- Behrens H. & Karber S. 1953 Determination of LD50. Archiv fur Experimentelle Pathologie und Pharmakologie 2, 177–372.
-
- Benedusi M., Tamburini E., Sicurella M., Summa D., Ferrara F., Marconi P., Cervellati F., Costa S. & Valacchi G. 2022 The lesson learned from the COVID-19 pandemic: Can an active chemical be effective, safe, harmless-for-humans and low-cost at a time? Evidence on aerosolized hypochlorous acid. International Journal of Environmental Research and Public Health 19, 13163. doi: 10.3390/ijerph192013163. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
